{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:56:08Z","timestamp":1773899768347,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.diabres.2023.110649","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T20:36:27Z","timestamp":1680294987000},"page":"110649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antidepressant and antipsychotic drug prescribing and diabetes outcomes: A systematic review of observational studies"],"prefix":"10.1016","volume":"199","author":[{"given":"Charlotte R.L.","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Ward-Penny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna F.","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110649_b0005","unstructured":"National Institute for Health and Care Excellence. BNF treatment summary: Antidepressant drugs [Internet]. 2021 [cited 2022 Nov]. Available from: https:\/\/bnf.nice.org.uk\/treatment-summary\/antidepressant-drugs.html."},{"key":"10.1016\/j.diabres.2023.110649_b0010","unstructured":"National Institute for Health and Care Excellence. BNF treatment summary: Psychoses and related disorders [Internet]. 2021 [cited 2022 Nov]. Available from: https:\/\/bnf.nice.org.uk\/treatment-summary\/psychoses-and-related-disorders.html."},{"key":"10.1016\/j.diabres.2023.110649_b0015","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0269881119827888","article-title":"Pharmaco-epidemiology of antidepressant exposure in a UK cohort record-linkage study","volume":"33","author":"Hafferty","year":"2019","journal-title":"J Psychopharmac"},{"key":"10.1016\/j.diabres.2023.110649_b0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","article-title":"International trends in antipsychotic use: A study in 16 countries, 2005\u20132014","volume":"27","author":"H\u00e1lfd\u00e1narson","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.diabres.2023.110649_b0025","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.diabres.2023.110649_b0030","article-title":"Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system","volume":"356","author":"Wong","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2023.110649_b0035","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2337\/dc13-0560","article-title":"Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review","volume":"36","author":"Barnard","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110649_b0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40261-021-01000-1","article-title":"Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects","volume":"41","author":"Rognoni","year":"2021","journal-title":"Clin Drug invest"},{"key":"10.1016\/j.diabres.2023.110649_b0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00228-016-2187-x","article-title":"Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies","volume":"73","author":"Biffi","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2023.110649_b0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12888-019-2177-5","article-title":"Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis","volume":"19","author":"Zivkovic","year":"2019","journal-title":"BMC Psych"},{"key":"10.1016\/j.diabres.2023.110649_b0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.diabres.2023.110649_b0060","unstructured":"National Institute for Health and Care Excellence. BNF treatment summary: Neuropathic pain. 2021 [cited 2022 Nov]. Available from: https:\/\/bnf.nice.org.uk\/treatment-summary\/neuropathic-pain.html."},{"key":"10.1016\/j.diabres.2023.110649_b0065","article-title":"Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression","volume":"12: Cd008381","author":"Baumeister","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diabres.2023.110649_b0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/neu.2016.54","article-title":"Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review","volume":"29","author":"Roopan","year":"2017","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1016\/j.diabres.2023.110649_b0075","unstructured":"Wells G, Shea B, O'Connell D, Robertson J, Peterson J, Welch V. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"10.1016\/j.diabres.2023.110649_b0080","first-page":"20","article-title":"Achievement of glycemic control and antidepressant medication use in comorbid depression and type II diabetes","author":"Brieler","year":"2022","journal-title":"Annals Fam Med"},{"key":"10.1016\/j.diabres.2023.110649_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2021.06.078","article-title":"Antidepressants and the risk of myocardial infarction among patients with diabetes: A population-based cohort study","volume":"294","author":"Chen","year":"2021","journal-title":"J Affective Disorders"},{"key":"10.1016\/j.diabres.2023.110649_b0090","article-title":"Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.diabres.2023.110649_b0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/dc18-0575","article-title":"Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes","volume":"42","author":"Hazuda","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110649_b0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/dme.12822","article-title":"Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: a nationwide register study","volume":"33","author":"R\u00e5dholm","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2023.110649_b0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00125-020-05303-4","article-title":"The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA(1c)\/LDL target achievement in newly diagnosed type 2 diabetes","volume":"64","author":"Rohde","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.110649_b0110","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2337\/dc12-1871","article-title":"Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes","volume":"36","author":"Rubin","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110649_b0115","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4088\/JCP.v65n0512","article-title":"Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus","volume":"65","author":"Spoelstra","year":"2004","journal-title":"J Clin Psych"},{"key":"10.1016\/j.diabres.2023.110649_b0120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/schbul\/sbv187","article-title":"Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus","volume":"42","author":"Wu","year":"2016","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.diabres.2023.110649_b0125","first-page":"e5136","article-title":"Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus","volume":"106","author":"Wu","year":"2021","journal-title":"J Clin Endocrinol metab"},{"key":"10.1016\/j.diabres.2023.110649_b0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/joim.12512","article-title":"Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to stroke","volume":"280","author":"W\u00fcrtz","year":"2016","journal-title":"J Int Med"},{"key":"10.1016\/j.diabres.2023.110649_b0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/JCP.0000000000001508","article-title":"A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes","volume":"42","author":"Rohde","year":"2022","journal-title":"J ClinlPpsychopharmacol"},{"key":"10.1016\/j.diabres.2023.110649_b0140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archinternmed.2009.207","article-title":"Antipsychotic drugs and hyperglycemia in older patients with diabetes","volume":"169","author":"Lipscombe","year":"2009","journal-title":"Archives Int Med"},{"key":"10.1016\/j.diabres.2023.110649_b0145","doi-asserted-by":"crossref","first-page":"e1124","DOI":"10.4088\/JCP.15m10048","article-title":"Selective Serotonin Reuptake Inhibitors Decrease Pancreatic Insulin Secretion in Older Adults and Increase the Risk of Insulin Dependence in Type 2 Diabetes Patients","volume":"77","author":"Noordam","year":"2016","journal-title":"J Clin Psych"},{"key":"10.1016\/j.diabres.2023.110649_b0150","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.diabres.2006.06.002","article-title":"An examination of the moderating effect of treatment with anti-depressants on the association of heart disease with depression in males with type 2 diabetes attending a Veterans Affairs Medical Center","volume":"75","author":"Higgins","year":"2007","journal-title":"Diabetes Res Clin Prac"},{"key":"10.1016\/j.diabres.2023.110649_b0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jdiacomp.2015.10.017","article-title":"The association between antidepressant use and glycemic control in the Southern Community Cohort Study (SCCS)","volume":"30","author":"Kammer","year":"2016","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabres.2023.110649_b0160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.psyneuen.2016.01.022","article-title":"Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study","volume":"66","author":"Wake","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.diabres.2023.110649_b0165","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jdiacomp.2015.06.009","article-title":"The association of antidepressant medications and diabetic retinopathy among people with diabetes","volume":"29","author":"Yekta","year":"2015","journal-title":"J Diabetes Complica"},{"key":"10.1016\/j.diabres.2023.110649_b0170","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000477940","article-title":"The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis","volume":"86","author":"Maslej","year":"2017","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.diabres.2023.110649_b0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.diabres.2023.110649_b0180","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1017\/S0033291717000873","article-title":"Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis","volume":"47","author":"Vermeulen","year":"2017","journal-title":"Psychol Med"},{"key":"10.1016\/j.diabres.2023.110649_b0185","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/0269881117714047","article-title":"Myocardial infarction risk and antipsychotics use revisited: a meta-analysis of 10 observational studies","volume":"31","author":"Huang","year":"2017","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.diabres.2023.110649_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: a meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2023.110649_b0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.9740\/mhc.2017.11.246","article-title":"Management of serious cardiac adverse effects of antipsychotic medications","volume":"7","author":"Stoner","year":"2017","journal-title":"Mental Health Clin"},{"key":"10.1016\/j.diabres.2023.110649_b0200","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1530\/EJE-18-0022","article-title":"Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation","volume":"178","author":"Whicher","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2023.110649_b0205","article-title":"Antidepressant utilisation and incidence of weight gain during 10 years' follow-up: population based cohort study","volume":"361","author":"Gafoor","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2023.110649_b0210","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/dme.14054","article-title":"Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis","volume":"36","author":"Nouwen","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2023.110649_b0215","first-page":"272","article-title":"Effects of severe mental illness on survival of people with diabetes","volume":"197","author":"Vinogradova","year":"2010","journal-title":"BJPsych"},{"key":"10.1016\/j.diabres.2023.110649_b0220","first-page":"450","article-title":"Complications and mortality in patients with schizophrenia and diabetes: population-based cohort study","volume":"207","author":"Wu","year":"2015","journal-title":"BJPsych"},{"key":"10.1016\/j.diabres.2023.110649_b0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"Hert","year":"2011","journal-title":"World Psychiatry"},{"key":"10.1016\/j.diabres.2023.110649_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110026","article-title":"Severe mental illness and quality of care for type 2 diabetes: A retrospective population-based cohort study","volume":"190","author":"Scheuer","year":"2022","journal-title":"Diabetes Res Clin Prac"},{"key":"10.1016\/j.diabres.2023.110649_b0235","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008650","article-title":"Primary care consultation rates among people with and without severe mental illness: a UK cohort study using the Clinical Practice Research Datalink","volume":"5","author":"Kontopantelis","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabres.2023.110649_b0240","doi-asserted-by":"crossref","first-page":"19583","DOI":"10.1038\/s41598-020-76546-9","article-title":"Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Sci Rep"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:26:53Z","timestamp":1759174013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723004096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":48,"alternative-id":["S0168822723004096"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110649","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant and antipsychotic drug prescribing and diabetes outcomes: A systematic review of observational studies","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110649"}}